News

The Latest

Marken Assists in Fight Against Polio

Marken Leads Logistics for Urgent Vaccine Need in Papua New Guinea      Research Triangle Park, NC, November 6, 2018 – Marken shared news today of a coordinated project for shipments of biological samples to test for the presence of the polio virus in Papua New Guinea...

  • Marken Assists in Fight Against Polio

    Marken Leads Logistics for Urgent Vaccine Need in Papua New Guinea      Research Triangle Park, NC, November 6, 2018 – Marken shared news today of a coordinated project for shipments of biological samples to test for the presence of the polio virus in Papua New Guinea (PNG).  An outbreak of the virus across areas… Read more »

  • Preparing Clinical Trial Logistics for a No-Deal Brexit

    Pharma’s Almanac – Q4 2018 Despite many discussions, no agreement has been reached on the exit of Britain (Brexit) from the European Union. With less than six months to go, it is increasingly possible that a no-deal, hard break will take place on March 29, 2019. To prevent the worst scenario — interruption of the… Read more »

  • Hurricane Willa (Mexico)

    Hurricane Willa, a Category 5 hurricane capable of catastrophic damage, is nearing Mexico’s Pacific coast. As the storm strengthens, it is expected to make an impact on Tuesday afternoon (October 23). Marken has contingency plans in place for shipments located the region. Clients may reach out to their local Marken office for information on a… Read more »

  • The Changing Face of Clinical Trials

    Traditional trial strategies often bring challenges to patient recruitment and retention. Sponsors are eagerly embracing the value that hybrid and virtual trials offer, and are exploring how logistics and supply chain experts like Marken can work closely with them and with patients through these types of trials.

  • Marken Announces Global Brokerage Management Services for Clinical Trial Materials

    New Centralized Service Speeds Shipments and Reduces Import/Export Risk     Research Triangle Park, NC, October 16, 2018 – Marken announced today the launch of their brokerage management services in conjunction with UPS Brokerage to create one seamless offering with optimal visibility and ease of use for clients.   The addition of this service will… Read more »

  • Hurricane Michael

    For information on shipments moving into or out of regions in the path of Hurricane Michael, please contact your local Marken office for more details about the contingency plans that are already in place to reduce impact on shipments.   Update – Wednesday, October 10: Hurricane Michael has made landfall as a powerful, Category 4… Read more »

  • Pharma’s Almanac: Personalized Logistics Solutions for Virtual and Hybrid Clinical Trials

    The pharmaceutical industry is moving toward siteless/hybrid clinical trials. Implementing such complex studies requires participation from all members of the supply chain and the support of an experienced service provider that can ensure the development of appropriate protocol designs.

  • Are you ready for a no-deal Brexit? We are.

    The clock is ticking As it stands, there are less than 6 months to negotiate – but more importantly, less than 6 months to prepare for any potential outcome of the negotiations. If the UK leaves the EU under a no-deal Brexit, this would affect the regulations of medicines, medical devices and clinical trials. Potential… Read more »

  • Marken Opens Kit Assembly and Shipment Facility in Miami

    New Miami Kit Building Facility Serves the Americas: Completes Global Network   Research Triangle Park, NC, October 2, 2018 – Marken announced the opening of its newest kit-building facility in Miami, completing a global network of four locations, with integrator-based distribution to any investigator site in the world.   The new facility is co-located with… Read more »

  • Personalized Logistics Solutions for Virtual and Hybrid Clinical Trials

    The pharmaceutical industry is moving toward siteless/hybrid clinical trials. Implementing such complex studies requires participation from all members of the supply chain and the support of an experienced service provider that can ensure the development of appropriate protocol designs.   Patient Centricity and the Growing Interest in Siteless/Hybrid Trials In virtual or siteless trials, patients do… Read more »

  • Show More